Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

This Dividend Growth Stock Is a Screaming Buy

TheMotleyFool

0 0

Dividend growth stocks have generated higher annual total returns than all other stocks (i.e., non-dividend-paying stocks and other dividend-paying stocks) from 1973 to 2021. And this appears to still be the case in 2022.

As a case in point, pharma stock Eli Lilly (NYSE: LLY) has only fallen 1% year to date. This is significantly better than the S&P 500's 11% decline during that time. And better yet, I believe Eli Lilly can continue to outperform the S&P 500 going forward. Let's dive deeper into the stock's fundamentals and valuation to find out why.

Image source: Getty Images.

Source Fool.com

Like: 0

LLY

Share